Terms: = Bone cancer AND ERG, P11308, 2078 AND Treatment
43 results:
1. Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
2. Complex/cryptic
Zou YS; Morsberger L; Hardy M; Ghabrial J; Stinnett V; Murry JB; Long P; Kim A; Pratilas CA; Llosa NJ; Ladle BH; Lemberg KM; Levin AS; Morris CD; Haley L; Gocke CD; Gross JM
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372318
[TBL] [Abstract] [Full Text] [Related]
3. Gingival metastasis of angiosarcoma of the breast as a first manifestation of spreading disease: Case report and review of the literature.
Mota ME; Tomo S; Alves FA; Pellissari GA; do Nascimento AG; Lopes RN
Spec Care Dentist; 2024; 44(2):458-464. PubMed ID: 37341541
[TBL] [Abstract] [Full Text] [Related]
4. [Epidemiological and clinicopathological characteristics of prostate cancer in Hunan].
Zou B; Long Y; Yang ZM; Gao RS; Lin QF; Dai XJ; Yi G; Wang QZ; Zhou Q; Zhang XB
Zhonghua Nan Ke Xue; 2022 Sep; 28(9):786-791. PubMed ID: 37839003
[TBL] [Abstract] [Full Text] [Related]
5. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Liu AJ; Kosiorek HE; Ueberroth BE; Jaeger E; Ledet E; Kendi AT; Tzou K; Quevedo F; Choo R; Moore CN; Ho TH; Singh P; Keole SR; Wong WW; Sartor O; Bryce AH
Prostate; 2022 Sep; 82(12):1202-1209. PubMed ID: 35652618
[TBL] [Abstract] [Full Text] [Related]
6. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-erg gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
7. Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissue.
Paulsen FO; Kang D; Becker F; Roth D; Joerg V; Dreyer E; Roesch MC; Seidel C; Merseburger AS; Kirfel J; Sailer V; Offermann A; Perner S
Carcinogenesis; 2022 Sep; 43(8):779-786. PubMed ID: 35512686
[TBL] [Abstract] [Full Text] [Related]
8. Autoimmune retinopathy: clinical, electrophysiological, and immunological features in nine patients with long-term follow-up.
Safadi K; Chowers I; Banin E; Rosin B; Tiosano L; Amer R
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):975-991. PubMed ID: 34591174
[TBL] [Abstract] [Full Text] [Related]
9. Maxillary epithelioid hemangioendothelioma: an especially rare malignant tumor mimicking periodontal disease.
Januzis G; Sakalys D; Krukis MM; Seinin D
BMC Oral Health; 2020 Nov; 20(1):309. PubMed ID: 33158420
[TBL] [Abstract] [Full Text] [Related]
10. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.
Laurent AP; Kotecha RS; Malinge S
Leukemia; 2020 Aug; 34(8):1984-1999. PubMed ID: 32433508
[TBL] [Abstract] [Full Text] [Related]
11. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.
Perret R; Escuriol J; Velasco V; Mayeur L; Soubeyran I; Delfour C; Aubert S; Polivka M; Karanian M; Meurgey A; Le Guellec S; Weingertner N; Hoeller S; Coindre JM; Larousserie F; Pierron G; Tirode F; Le Loarer F
Mod Pathol; 2020 Oct; 33(10):1930-1944. PubMed ID: 32327700
[TBL] [Abstract] [Full Text] [Related]
12. TMPRSS2-erg fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model.
Semaan L; Mander N; Cher ML; Chinni SR
BMC Cancer; 2019 Oct; 19(1):972. PubMed ID: 31638934
[TBL] [Abstract] [Full Text] [Related]
13. Angiosarcoma of the Temporal bone: Case Report and Review of the Literature.
Bernstock JD; Shafaat O; Hardigan A; Fox BM; Moore LS; Chagoya G; Elsayed G; Gessler F; Ilyas A; Yamashita D; McGrew B; Fisher WS; Hackney J; Sotoudeh H
World Neurosurg; 2019 Oct; 130():351-357. PubMed ID: 31330332
[TBL] [Abstract] [Full Text] [Related]
14. Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.
Ma Y; Baltezor M; Rajewski L; Crow J; Samuel G; Staggs VS; Chastain KM; Toretsky JA; Weir SJ; Godwin AK
J Mol Med (Berl); 2019 Jul; 97(7):957-972. PubMed ID: 31025088
[TBL] [Abstract] [Full Text] [Related]
15. Primary pseudomyogenic hemangioendothelioma of bone: case report and review of the literature.
Squillaci S; Pitino A; Spairani C; Rassu PC; Chiapuzzo E; Kutzner H
Pathologica; 2018 Sep; 110(2):96-101. PubMed ID: 30546145
[TBL] [Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-erg-positive cases.
Tomizawa D; Yoshida M; Kondo T; Miyamura T; Taga T; Adachi S; Koh K; Noguchi M; Kakuda H; Watanabe K; Cho Y; Fukuda T; Kato M; Shiba N; Goto H; Okada K; Inoue M; Hashii Y; Atsuta Y; Ishida H
Bone Marrow Transplant; 2019 Mar; 54(3):393-401. PubMed ID: 29959436
[TBL] [Abstract] [Full Text] [Related]
17. Metastatic squamous cell carcinoma with pseudoangiosarcomatous features and aberrant expression of vascular markers.
Carney JM; Wang L; Bentley R; Cardona DM; Zhang X
Pathol Res Pract; 2018 Oct; 214(10):1732-1737. PubMed ID: 29933892
[TBL] [Abstract] [Full Text] [Related]
18. The clinical features of epithelioid hemangioendothelioma in a Han Chinese population: A retrospective analysis.
Guo Q; Xue J; Xu L; Shi Z; Zhou B
Medicine (Baltimore); 2017 Jun; 96(26):e7345. PubMed ID: 28658152
[TBL] [Abstract] [Full Text] [Related]
19. LuCaP Prostate cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating cancer Therapeutics.
Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
[TBL] [Abstract] [Full Text] [Related]
20. Cabazitaxel for Hormone-Relapsed Metastatic Prostate cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Kearns B; Pandor A; Stevenson M; Hamilton J; Chambers D; Clowes M; Graham J; Kumar MS
Pharmacoeconomics; 2017 Apr; 35(4):415-424. PubMed ID: 27770303
[TBL] [Abstract] [Full Text] [Related]
[Next]
